Find Funding Opportunities

Notice Intent Publish Funding Opportunity Announcement NINDS Morris K. Udall Centers Excellence Parkinson's Disease Research P50 Clinical Trial Optional) Notice Number: NOT-NS-20-057 Key Dates Release Date: April 30, 2020 Estimated Publication Date Funding Opportunity Announcement: June 25, 2020 First Estimated Application Due Date: September 25, 2020 Earliest Estimated Award Date: July 01, 2021Earliest Estimated Start Date: July 01, 2021 Related Announcements NOT-NS-20-058 Issued National Institute Neurological Disorders Stroke NINDS) Purpose National Institute Neurological Disorders Stroke NINDS) intends publish Funding Opportunity Announcement FOA) solicit applications the Morris K. Udall Centers Excellence Parkinson's Disease Research program. overarching goal this program to establish network specialized Centers work collaboratively well independently define causes and discover improved treatments Parkinson’s disease PD). more immediate goal each Center to rapidly advance synergistic, interdisciplinary research programs while serving national leaders PD research. Udall Centers also serve local resources providing research career enhancement activities Center investigators periodic outreach the PD patient/advocacy community Notice being provided allow potential applicants sufficient time develop meaningful collaborations responsive projects. FOA expected be published Summer 2020 an expected application due date Autumn 2020. FOA utilize P50 activity code. Details the planned FOA provided below. Ressearch Initiative Details Notice encourages investigators expertise insights this area Parkinson's Disease PD) begin consider applying this new FOA. Among areas research encouraged this initiative interdisciplinary research collaborations examining mechanisms underlie effects PD, well research designed improve translation existing knowledge strategies the prevention treatment PD. Applicants the Udall Centers program identify address overall research theme defines critical challenge PD research. Center theme, proposed research projects, associated cores inform etiology, pathogenesis treatment PD; investigations related synucleinopathies be included such directly address identified PD research challenge. Programmatic requirements this FOA include: three more Research Projects, including dedicated Udall Catalyst project led a junior investigator; Administrative Core; least integrated Research Core is essential and accelerates progress two more Research Projects; mission statement career enhancement Center investigators, a plan periodic outreach the local patient/advocacy community, including specific outreach events convey Center research advances. NINDS Udall Centers program prioritizes innovative integrative research significant potential discovery. Considerable synergy must evident among Center research projects cores, such the Center structure required successful completion the aims. Udall Center Director PD/PI) must a leader scientific research visionary leadership skills proven expertise the stewardship large-scale research programs; participating investigators must lead independent research programs, the exception the Udall Catalyst project investigator. Applicant institutions must provide solid evidence commitment the proposed Udall Center. Only new applications be accepted response this FOA. project period be five years. Funding decisions focus those applications most likely make significant contributions PD research, well those greatest potential collaborate effectively across Udall Centers program. Funding Information Estimated Total FundingThe NINDS intents commit to 6,750,000 total costs fiscal year FY) 2021. number awards contingent upon NIH appropriations the submission a sufficient number meritorious applications. Expected Number Awards3 Estimated Award Ceiling: Applicants request to 1,000,000 direct costs per year the following exception: applications containing translational project and/or clinical component i.e. clinical research project plus clinical core) request to 1,500,000 direct costs per year. Application budgets must justify reflect actual needs the proposed project. Primary CFDA Numbers98.853 Anticipated Eligible Organizations Public/State Controlled Institution Higher Education U.S. Territory Possession Indian/Native American Tribal Government than Federally Recognized) Indian/Native American Tribally Designated Organization Native American tribal organizations than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Independent school districts County governments Indian/Native American Tribal Government Federally Recognized) State Government For-Profit Organization than Small Business) Small Business Nonprofit 501(c)(3) IRS Status than Institution Higher Education) Private Institution Higher Education Regional Organization Non-domestic non-U.S.) Entity Foreign Organization) Eligible Agencies the Federal Government Applications not being solicited this time. Inquiries Please direct inquiries to: Beth-Anne Sieber, PhDNational Institute Neurological Disorders Stroke NINDS)(301) 496-5680 Beth-Anne.Sieber@nih.gov nbsp; nbsp;

Notice Intent Publish Funding Opportunity Announcement NINDS Exploratory Grant Program Parkinson's Disease Research P20- Clinical Trial Optional) P20 Clinical Trial Optional) Notice Number: NOT-NS-20-058 Key Dates Release Date: April 30, 2020 Estimated Publication Date Funding Opportunity Announcement: June 25, 2020 First Estimated Application Due Date: September 25, 2020 Earliest Estimated Award Date: July 01, 2021 Earliest Estimated Start Date: July 01, 2021 Related Announcements None Issued National Institute Neurological Disorders Stroke NINDS) Purpose National Institute Neurological Disorders Stroke NINDS) intends publish Funding Opportunity Announcement FOA) solicit applications an Exploratory Grant Program Parkinson's Disease Research. initiative request Exploratory Grantapplications the planning initiation collaborative efforts advance Parkinson's Disease PD) research. goal this program to formalize new interdisciplinary teams address critical gaps PD research establish foundation research discovery leading directly an NINDS Morris K. Udall Center Excellence PD Research P50) application. Notice being provided allow potential applicants sufficient time develop meaningful collaborations responsive projects. FOA expected be published Summer 2020 an expected application due date Autumn 2020. FOA utilize Exploratory Grant P20) activity code. Details the planned FOA provided below. Ressearch Initiative Details Notice encourages investigators expertise insights Parkinson's Disease PD) research begin consider applying this new FOA. initiative encourages PD research examining mechanisms underlie effects PD, well research designed improve translation existing knowledge strategies the prevention treatment PD. purpose this FOA Exploratory Grant P20) applications to support formation new interdisciplinary research teams innovative approaches address current challenges PD research. Through mechanism, NINDS seeks develop synergistic, proof-of-concept research efforts around investigator-defined thematic areas. overall goal to encourage formation new collaborative teams develop novel research plan, construct effective administrative organization, create standardized policies/procedures, gather rigorous preliminary data support novel ideas address urgent gaps emergent issues PD research. Successful Exploratory Grant activities should lead directly the submission a competitive NINDS Morris K. Udall Center Excellence (P50) application.? P20 application include Overall section, Administrative Core a minimum three research feasibility projects, of will led an Early Stage Investigator ESI). Research Cores not within scope. Exploratory Grant provide to years support. NINDS funding decisions focus primarily scientific merit, i.e., those applications are most likely make innovative contributions PD research that demonstrate potential submit Udall Center application the end the Exploratory Grant project period. Funding Information Estimated Total FundingThe NINDS intends commit to 1,800,000 FY2021. number awards contingent upon NIH appropriations the submission sufficiently meritorious applications. Expected Number Awards4 Estimated Award Ceiling Application budgets limited 300,000 direct costs per year exclusive facilities administrative costs subcontracts collaborating institutions). Budget requests should reflect actual needs the proposed project. Primary CFDA Numbers 93.853 Anticipated Eligible Organizations Private Institution Higher Education Public/State Controlled Institution Higher Education Nonprofit 501(c)(3) IRS Status than Institution Higher Education) Small Business For-Profit Organization than Small Business) State Government Indian/Native American Tribal Government Federally Recognized) County governments Independent school districts Public housing authorities/Indian housing authorities Indian/Native American Tribally Designated Organization Native American tribal organizations than Federally recognized tribal governments) U.S. Territory Possession Indian/Native American Tribal Government than Federally Recognized) Regional Organization Eligible Agencies the Federal Government Applications not being solicited this time. Inquiries Please direct inquiries to: Beth-Anne Sieber, PhDNational Institute Neurological Disorders Stroke NINDS)(301) 496-5680 Beth-Anne.Sieber@nih.gov  

Notice Change Key Dates PAR-18-469 NINDS Advanced Postdoctoral Career Transition Award Promote Diversity Neuroscience Research K22-No Independent Clinical Trials)" Notice Number: NOT-NS-20-065 Key Dates Release Date: 01, 2020 Related Announcements PAR-18-469 - NINDS Advanced Postdoctoral Career Transition Award Promote Diversity Neuroscience Research K22-No Independent Clinical Trials) Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this notice to inform interested applicants a change the Key Dates PAR-18-469 NINDS Advanced Postdoctoral Career Transition Award Promote Diversity Neuroscience Research K22-No Independent Clinical Trials)". funding opportunity announcements been extended one additional council round. dates been modified add following New Application Due Date: February 12, 2021, Resubmission Date: March 12, 2021, AIDS application Due Date: 7, 2021. Currently Reads: Part 1. Overview Information Key Dates: Application Due Date(s) Standard dates apply, 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) Standard AIDS dates apply, 5:00 PM local time applicant organization. All types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review Standard dates apply Advisory Council Review Standard dates apply Earliest Start Date Standard dates apply Expiration Date January 8, 2021 Modified Read: Part 1. Overview Information Key Dates: Application Due Date(s) Standard dates apply, 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) Standard AIDS dates apply, 5:00 PM local time applicant organization. All types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review Standard dates apply Advisory Council Review Standard dates apply Earliest Start Date Standard dates apply Expiration Date 8, 2021 other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Michelle Jones-London, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-451-7966 Email: jonesmiche@ninds.nih.gov

Notice Extension Expiration Date PAR-17-456 CREATE Bio Optimization Track Biologics U01 Clinical Trial Allowed)" Notice Number: NOT-NS-20-053 Key Dates Release Date: April 28, 2020 Related Announcements PAR-17-456 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform interested applicants the expiration date the Funding Opportunity Announcement FOA) PAR-17-456 CREATE Bio Optimization Track Biologics U01 Clinical Trial Allowed)" be extended. additional non-AIDS application due date February 12, 2021 AIDS AIDS-related applications due date May 7, 2021 been added this FOA. FOA expires May 8, 2021. Changes shown in bold italics below. Key Dates table updated accordingly: Part 1. Overview Information Key Dates Application Due Date(s) February 13, 2018; July 18, 2018; February 13, 2019; July 18, 2019; February 13, 2020; July 20, 2020, 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) 7, 2018; September 7, 2018; 7, 2019; September 7, 2019; 7, 2020; September 7, 2020, 5:00 PM local time applicant organization. All types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review June 2018; November 2018; June 2019; November 2019; June 2020; November 2020 Advisory Council Review October 2018; January 2019; October 2019; January 2020; October 2020; January 2021 Earliest Start Date December 2018 Expiration Date September 8, 2020 Modified Read: Application Due Date(s) February 13, 2018; July 18, 2018; February 13, 2019; July 18, 2019; February 13, 2020; July 20, 2020 , February 12, 2021 by 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) 7, 2018; September 7, 2018; 7, 2019; September 7, 2019; 7, 2020; September 7, 2020, May 7, 2021 by 5:00 PM local time applicant organization. All types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review June 2018; November 2018; June 2019; November 2019; June 2020; November 2020, June 2021 Advisory Council Review October 2018; January 2019; October 2019; January 2020; October 2020; January 2021, October 2021 Earliest Start Date December 2018 Expiration Date 8, 2021 other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Chris Boshoff, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: chris.boshoff@nih.gov

Notice Extension Expiration Date PAR-17-457 CREATE Bio Optimization Track Biologics SBIR) U44 Clinical Trial Allowed)" Notice Number: NOT-NS-20-054 Key Dates Release Date: April 28, 2020 Related Announcements PAR-17-457 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform interested applicants the expiration date the Funding Opportunity Announcement FOA) PAR-17-457 CREATE Bio Optimization Track Biologics SBIR) U44 Clinical Trial Allowed)" be extended. additional non-AIDS application due date February 12, 2021 AIDS AIDS-related applications due date May 7, 2021 been added this FOA. FOA expires May 8, 2021. Changes shown in bold italics below. Key Dates table updated accordingly: Part 1. Overview Information Key Dates Application Due Date(s) February 13, 2018; July 18, 2018; February 13, 2019; July 18, 2019; February 13, 2020; July 20, 2020 , 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) 7, 2018; September 7, 2018; 7, 2019; September 7, 2019; 7 2020; September 7, 2020, 5:00 PM local time applicant organization. All types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review June 2018; November 2018; June 2019; November 2019; June 2020; November 2020 Advisory Council Review October 2018; January 2019; October 2019; January 2020; October 2020; January 2021 Earliest Start Date December 2018 Expiration Date September 8, 2020 Modified Read: Application Due Date(s) February 13, 2018; July 18, 2018; February 13, 2019; July 18, 2019; February 13, 2020; July 20, 2020 , February 12, 2021 by 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) 7, 2018; September 7, 2018; 7, 2019; September 7, 2019; 7, 2020; September 7, 2020, May 7, 2021 by 5:00 PM local time applicant organization. All types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review June 2018; November 2018; June 2019; November 2019; June 2020; November 2020, June 2021 Advisory Council Review October 2018; January 2019; October 2019; January 2020; October 2020; January 2021, October 2021 Earliest Start Date December 2018 Expiration Date 8, 2021 other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Chris Boshoff, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: chris.boshoff@nih.gov

Notice Extension Expiration Date PAR-18-542 CREATE Bio Development Track: Nonclinical Early-Phase Clinical Development Biologics U01 Clinical Trial Optional)" Notice Number: NOT-NS-20-055 Key Dates Release Date: April 28, 2020 Related Announcements PAR-18-542 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform interested applicants the expiration date the Funding Opportunity Announcement FOA) PAR-18-542 CREATE Bio Development Track: Nonclinical Early-Phase Clinical Development Biologics U01 Clinical Trial Optional)" be extended. additional non-AIDS application due date February 12, 2021 AIDS AIDS-related applications due date May 7, 2021 been added this FOA. FOA expires May 8, 2021. Changes shown in bold italics below. Key Dates table updated accordingly: Part 1. Overview Information Key Dates Application Due Date(s) February 20, 2018, July 18, 2018, February 13, 2019, July 18, 2019, February 13, 2020, July 20, 2020), 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) 7, 2018; September 7, 2018; 7, 2019; September 7, 2019; 7, 2020; September 7, 2020, 5:00 PM local time applicant organization. All types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review June 2018; November 2018; June 2019; November 2019; June 2020; November 2020 Advisory Council Review October 2018; January 2019; October 2019; January 2020; October 2020; January 2021 Earliest Start Date December 2018 Expiration Date September 8, 2020 Modified Read: Application Due Date(s) February 20, 2018, July 18, 2018, February 13, 2019, July 18, 2019, February 13, 2020, July 20, 2020), and February 12, 2021 by 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) 7, 2018; September 7, 2018; 7, 2019; September 7, 2019; 7, 2020; September 7, 2020, May 7, 2021 by 5:00 PM local time applicant organization. All types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review June 2018; November 2018; June 2019; November 2019; June 2020; November 2020, June 2021 Advisory Council Review October 2018; January 2019; October 2019; January 2020; October 2020; January 2021, October 2021 Earliest Start Date December 2018 Expiration Date 8, 2021 other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Chris Boshoff, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: chris.boshoff@nih.gov

Notice Extension Expiration Date PAR-18-543 CREATE Bio Development Track: Nonclinical Early-Phase Clinical Development Biologics U44 Clinical Trial Optional)" Notice Number: NOT-NS-20-056 Key Dates Release Date: April 28, 2020 Related Announcements PAR-18-543 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform interested applicants the expiration date the Funding Opportunity Announcement FOA) PAR-18-543 CREATE Bio Development Track: Nonclinical Early-Phase Clinical Development Biologics U44 Clinical Trial Optional)" be extended. additional non-AIDS application due date February 12, 2021 AIDS AIDS-related applications due date May 7, 2021 been added this FOA. FOA expires May 8, 2021. Changes shown in bold italics below. Key Dates table updated accordingly: Part 1. Overview Information Key Dates Application Due Date(s) February 20, 2018, July 18, 2018, February 13, 2019, July 18, 2019, February 13, 2020, July 20, 2020), 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) 7, 2018; September 7, 2018; 7, 2019; September 7, 2019; 7, 2020; September 7, 2020, 5:00 PM local time applicant organization. All types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review June 2018; November 2018; June 2019; November 2019; June 2020; November 2020 Advisory Council Review October 2018; January 2019; October 2019; January 2020; October 2020; January 2021 Earliest Start Date December 2018 Expiration Date September 8, 2020 nbsp; Modified Read: Application Due Date(s) February 20, 2018, July 18, 2018, February 13, 2019, July 18, 2019, February 13, 2020, July 20, 2020), and February 12, 2021 by 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) 7, 2018; September 7, 2018; 7, 2019; September 7, 2019; 7, 2020; September 7, 2020, May 7, 2021 by 5:00 PM local time applicant organization. All types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review June 2018; November 2018; June 2019; November 2019; June 2020; November 2020, June 2021 Advisory Council Review October 2018; January 2019; October 2019; January 2020; October 2020; January 2021, October 2021 Earliest Start Date December 2018 Expiration Date 8, 2021 other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Chris Boshoff, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: chris.boshoff@nih.gov

Notice Correction Key Dates RFA-NS-20-029 BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP U01 Clinical Trials Optional)" Notice Number: NOT-NS-20-063 Key Dates Release Date: April 28, 2020 Related Announcements RFA-NS-20-029 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this notice to notify potential applicants a correction the Key Dates RFA-NS-20-029 BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP U01 Clinical Trials Optional)". Advisory Council Review Earliest Start Dates been modified show correct dates. Changes show in bold italics below. changes effective immediately. Currently Reads: Part 1. Overview Information Key Dates Advisory Council Review January 2022 January 2023 Earliest Start Date February 2022 February 2023 Modified Read: Part 1. Overview Information Key Dates Advisory Council Review January 2021 January 2022 Earliest Start Date February 2021 February 2022 other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Karen K David, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-9964 Email:BRAINCircuits@nih.gov

Notice Change the Award Project Period PAR-19-197 Summer Research Education Experience Program R25 Clinical Trial Allowed)" Notice Number: NOT-NS-20-050 Key Dates Release Date: April 27, 2020 Related Announcements PAR-19-197 Issued National Institute Neurological Disorders Stroke NINDS) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Biomedical Imaging Bioengineering NIBIB) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) Purpose purpose this notice to notify potential applicants a change the Award Project Period PAR-19-197 "Summer Research Education Experience Program R25 Clinical Trial Allowed)". Additional language been added clarify funds be requested a minimum 8 weeks a maximum 15 weeks during summer academic break. Changes the FOA shown below bold italics. changes be effective the March 17, 2021 receipt date. Currently Reads: Part 2. Full Text Announcement Section II. Award Information Award Project Period project period up five years be requested. Modified Read: Part 2. Full Text Announcement Section II. Award Information Award Project Period project period up five years be requested. Funds be requested a minimum 8 weeks a maximum 15 weeks during summer academic break. other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Lauren Ullrich, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-451-7964 Email: lauren.ullrich@nih.gov

Notice Change Key Dates PAR-19-211 NINDS Institutional Research Training Program T32)" Notice Number: NOT-NS-20-059 Key Dates Release Date: April 24, 2020 Related Announcements PAR-19-211 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this notice to inform interested applicants a change one the receipt dates PAR-19-211 NINDS Institutional Research Training Program T32)". Specifically, May 27, 2020 receipt date been changed to June 29, 2020. Changes shown below in bold italics. Currently Reads: Part 1. Overview Information Key Dates Application Due Date(s) 29, 2019; June 29, 2020; 26, 2021, 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Modified Read: Part 1. Overview Information Key Dates Application Due Date(s) 29, 2019; June 29, 2020; 26, 2021, 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Stephen Korn, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-4188 Email: korns@ninds.nih.gov